Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial

Clinical trial NCT05545384 · RECRUITING

Trial details

NCT number: NCT05545384
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Demyelinating Syndrome

Start date: 2025-04-01
Primary completion: 2027-04-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.